SCHEMBL9627696

SCHEMBL9627696

CCC1=C(Cl)C(=O)c2ccccc2C1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.60
DNMT1 P26358 1/20 0.60
DNMT3L Q9UJW3 1/20 0.60
DNMT3A Q9Y6K1 1/20 0.60
MAPT P10636 9/20 0.55
HTT P42858 5/20 0.55
LMNA P02545 4/20 0.55
ALDH1A1 P00352 4/20 0.55
TDP1 Q9NUW8 3/20 0.55
MITF O75030 3/20 0.55
USP2 O75604 1/20 0.55
POLB P06746 1/20 0.55
FGFR1 P11362 1/20 0.49
FGFR2 P21802 1/20 0.49
FGFR4 P22455 1/20 0.49
FGFR3 P22607 1/20 0.49
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
KDM4E B2RXH2 3/20 0.47
HPGD P15428 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5820931 0.84 FGFR1 (0.57) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL30004167 0.84 FGFR1 (0.57) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL9628338 0.84 MAPT (0.56) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL10953110 0.81 IDO1 (0.52) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL9627850 0.80 PTPN1 (0.51) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL9628681 0.80 NSD2 (0.42) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL9627508 0.78 PTPN1 (0.54) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL10956573 0.78 PTPN1 (0.54) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL10954496 0.78 PTPN1 (0.54) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL9629385 0.78 FGFR1 (0.38) IDO1DNMT1DNMT3LDNMT3AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-5091558-A Topical administeration SYNTEX (U.S.A.) INC. (US) 1992-02-25 US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0150831-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS SYNTEX (U.S.A.) INC. (US) 1988-08-10 EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 US disclosed
EP-0150831-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1985-08-07 EP disclosed
US-4507241-A Method for the hydrocarbylation of naphthoquinone derivatives E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-03-26 US disclosed